Last Updated: June 25, 2026

Suppliers and packagers for KAPSPARGO SPRINKLE


✉ Email this page to a colleague

« Back to Dashboard


KAPSPARGO SPRINKLE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-008-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-008-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-009-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-009-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-010-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-010-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-011-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-011-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries Inc. 63304-008-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63304-008-30) 2018-02-07
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries Inc. 63304-009-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63304-009-30) 2018-02-07
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries Inc. 63304-010-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63304-010-30) 2018-02-07
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for KAPSPARGO SPRINKLE

Last updated: June 5, 2026

Kapspargo Sprinkle (S3652) Suppliers: Who Makes and Supplies the Drug Substance, Finished Dosage Form, and Packaging?

Kapspargo Sprinkle is a brand of sodium-free capsule sprinkle formulation of metoprolol (metoprolol succinate). Supplier visibility depends on the specific strength, dosage form, and market, because manufacturers and contract packagers can vary by lot and regulatory submission.

No supplier roster can be produced from the information available in this prompt without generating an incomplete or inaccurate list.


What company supplies Kapspargo Sprinkle (metoprolol succinate) in the US?

No complete, reliable supplier mapping can be compiled here without access to the underlying supply-chain identifiers tied to Kapspargo Sprinkle’s commercial product (e.g., FDA labeling “Manufactured for/Distributed by,” Orange Book “Applicant,” NDA/ANDA drug substance and drug product manufacturers, and CMC site details by strength).


Which manufacturers make the drug substance and finished capsules/sprinkles for Kapspargo Sprinkle?

A defensible answer requires linking:

  • the NDA holder/applicant and drug product manufacturer listed on the FDA approval package and labeling,
  • drug substance sites referenced in the CMC dossier,
  • and any CMO/packager named on the label or in FDA inspections.

Those details are not present in the prompt, so no accurate supplier breakdown can be stated.


What do the label and Orange Book list for manufacturing sites of Kapspargo Sprinkle?

A supplier list is typically derived from:

  • Orange Book entries for the approved application and application type (NDA),
  • the applicant and patent owner for the product family,
  • and labeling fields such as “Manufactured for,” “Distributed by,” or “Packaged by.”

None of those listings are included in the prompt.


Who supplies Kapspargo Sprinkle packaging (bottles, closures, unit-of-use) for pharmacies?

Packaging vendors and contract packagers are commonly not disclosed in a single public record. The correct supplier identification requires lot-level or submission-level CMC/label-source data. That data is not included here.


Which contract manufacturing organizations (CMOs) support Kapspargo Sprinkle?

CMO identification requires CMC manufacturing site disclosures or FDA inspection reporting tied to the NDA. Without those sources in the input, no verified CMO list can be provided.


How does Kapspargo Sprinkle sourcing differ by strength (e.g., 15 mg, 25 mg, 50 mg)?

Strength-specific manufacturing and packaging can differ. A strength-by-strength supplier table cannot be generated without strength-specific labeling or Orange Book/approval package data.


What regulatory filings identify Kapspargo Sprinkle suppliers (NDA, labeling, CMC sites)?

Regulatory filing identification requires citation to:

  • FDA Drugs@FDA pages,
  • the NDA approval letter package,
  • and the Orange Book listing tied to each dosage strength.

Those filing identifiers are not available in the prompt.


Key Takeaways

  • A supplier roster for Kapspargo Sprinkle cannot be reliably produced from the provided information.
  • Accurate supplier identification requires the specific NDA/Orange Book/applicant/manufacturing-site records and strength-specific label or CMC references.

FAQs

  1. Is Kapspargo Sprinkle manufactured by the same company that holds the NDA?
  2. Do packaging suppliers for Kapspargo Sprinkle change by strength or lot?
  3. Where can manufacturing sites for Kapspargo Sprinkle be confirmed in FDA records?
  4. Are contract manufacturing sites for Kapspargo Sprinkle disclosed on the carton or label?
  5. How do I map Kapspargo Sprinkle drug substance suppliers versus finished dosage form suppliers?

References

No sources were provided in the prompt to cite.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.